Moll Udina, A., Hernanz, I., Sainz de la Maza Serra, M. T., Pelegrín, L., Coelho Borges, A. I., Pazos, M., . . . Llorenç, V. (2023). Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: Real-world effectiveness and safety outcomes at 12 months.
Citación estilo ChicagoMoll Udina, Aina, Inés Hernanz, María Teresa Sainz de la Maza Serra, Laura Pelegrín, Ana Isabel Coelho Borges, Marta Pazos, Alfredo Adán Civera, y Victor Llorenç. Intravitreal Fluocinolone Acetonide 0.19 mg (ILUVIEN®) in Patients With Non-infectious Uveitis: Real-world Effectiveness and Safety Outcomes At 12 months. 2023.
Cita MLAMoll Udina, Aina, et al. Intravitreal Fluocinolone Acetonide 0.19 mg (ILUVIEN®) in Patients With Non-infectious Uveitis: Real-world Effectiveness and Safety Outcomes At 12 months. 2023.